![c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs in: Journal of Molecular Endocrinology Volume 65 Issue 2 (2020) c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs in: Journal of Molecular Endocrinology Volume 65 Issue 2 (2020)](https://jme.bioscientifica.com/view/journals/jme/65/2/images/full-JME-20-0020fig1.jpeg)
c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs in: Journal of Molecular Endocrinology Volume 65 Issue 2 (2020)
![Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma | Cell and Developmental Biology Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/504414/fcell-08-00055-HTML/image_m/fcell-08-00055-g001.jpg)
Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma | Cell and Developmental Biology
![Developing c-MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine Developing c-MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/608984/4860256/gr1.jpg)
Developing c-MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine
![MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S155608641533255X-gr1.jpg)
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
![Molecules | Free Full-Text | Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met Inhibitors Molecules | Free Full-Text | Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met Inhibitors](https://www.mdpi.com/molecules/molecules-25-00010/article_deploy/html/images/molecules-25-00010-g001.png)
Molecules | Free Full-Text | Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met Inhibitors
![Capmatinib cancer drug molecule (c-met inhibitor). 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), ca Stock Photo - Alamy Capmatinib cancer drug molecule (c-met inhibitor). 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), ca Stock Photo - Alamy](https://c8.alamy.com/comp/2CAER85/capmatinib-cancer-drug-molecule-c-met-inhibitor-3d-rendering-atoms-are-represented-as-spheres-with-conventional-color-coding-hydrogen-white-ca-2CAER85.jpg)
Capmatinib cancer drug molecule (c-met inhibitor). 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), ca Stock Photo - Alamy
PLOS ONE: The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma
![Therapeutic targeting of HGF/c-Met pathway. c-Met pathway inhibition... | Download Scientific Diagram Therapeutic targeting of HGF/c-Met pathway. c-Met pathway inhibition... | Download Scientific Diagram](https://www.researchgate.net/publication/345992769/figure/fig1/AS:963833761902594@1606807284679/Therapeutic-targeting-of-HGF-c-Met-pathway-c-Met-pathway-inhibition-can-be-achieved.png)
Therapeutic targeting of HGF/c-Met pathway. c-Met pathway inhibition... | Download Scientific Diagram
![Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges | Nature Reviews Clinical Oncology Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges | Nature Reviews Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrclinonc.2017.40/MediaObjects/41571_2017_Article_BFnrclinonc201740_Fig5_HTML.jpg)
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges | Nature Reviews Clinical Oncology
![MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-019-0759-9/MediaObjects/13045_2019_759_Fig5_HTML.png)
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
![Capmatinib cancer drug molecule (c-met inhibitor). 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), ca Stock Photo - Alamy Capmatinib cancer drug molecule (c-met inhibitor). 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), ca Stock Photo - Alamy](https://c8.alamy.com/comp/2CAER8A/capmatinib-cancer-drug-molecule-c-met-inhibitor-3d-rendering-atoms-are-represented-as-spheres-with-conventional-color-coding-hydrogen-white-ca-2CAER8A.jpg)